One of the two most common drugs used to treat age-related macular degeneration (AMD) appears better than the other, a new, small study suggests.
Among 106 patients with "wet" age-related macular degeneration, 50% of those treated with aflibercept (Eylea) could be weaned off the drug after one year, compared with only 17% of those treated with bevacizumab (Avastin), researchers found.
An off-brand medication for diabetic macular edema might prove just as effective in early treatment as its more expensive alternative, potentially saving patients thousands of dollars, new research suggests.
The vision condition is a common complication of poorly controlled diabetes, which can damage bl...
Untreated vision loss may put an older adult at an increased risk for dementia, though it's not clear why, according to a new study.
Researchers found that the likelihood of having some form of cognitive impairment was 137% higher in seniors who had trouble seeing than in those without vision issues. Cognitive impairment is a general term for problems with thinking and memory.
Keeping your drinking and your weight in check can help protect your sight as you age, experts say.
Moderate to heavy drinking is associated with a higher risk of a sight-threatening condition called age-related macular degeneration (AMD). A poor diet and excess weight can also influence your odds for AMD, the most common cause of blindness in Americans older than 50.
Early diagnosis and care can often stop the progression of age-related macular degeneration (AMD), which is the leading cause of vision loss in older Americans, the American Society of Retina Specialists (ASRS) says.
As part of AMD Awareness Month in February, the society urges people to pay attention to their vision and learn more about AMD.
Injection medications can save the vision of older people with macular degeneration, but the ongoing regimen is taxing. Now a preliminary study raises the possibility that some patients can safely be "weaned off" the treatment.
Researchers found that of just over 100 patients they treated with the eye injections, nearly one-third were able to "pause" the therapy within the first year. And...
Midlife vision problems could increase women's risk of depression, new research suggests.
Rates of eye problems and depression rise during midlife, but knowledge about how vision affects depression at that time has been limited. The new study identified a significant link between impaired vision and development of depression.
"Given that the combination of visual impairment and depr...
Diseases that can rob you of vision as you age also appear to be tied to an increased risk for dementia, a new study finds.
Specifically, age-related macular degeneration, cataracts and diabetes-related eye disease were linked with a higher likelihood of dementia, researchers in China said. However, one other common eye ailment, glaucoma, was not linked to dementia risk.
The new stu...
Steven Reinberg and Ernie Mundell HealthDay Reporters
A number of new treatments for age-related macular degeneration (AMD), a progressive eye disease, are under development. AMD is a leading cause of vision loss in older people.
About 11 million Americans have AMD, which affects part of the eye that allows you to see fine detail. There are two types: wet and dry. Wet AMD is treated with eye injections every month or two, and dry AMD with an...
A drug long used to treat Parkinson's disease may benefit patients with a severe form of age-related macular degeneration (AMD), a small clinical trial suggests.
One of the leading causes of vision loss in older people is a condition called dry macular degeneration. More than 15% of Americans over age 70 have AMD, and 10% to 15% of those cases go on to develop the more sev...
Missing just one eye doctor appointment can result in vision loss in older adults with macular degeneration, a new study warns.
Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly, and these findings show the need for patients to keep all scheduled appointments with an ophthalmologist, the University of Pennsylvania School of Medicine researchers sa...